Full Press Release Details
All Primers Perspectives Progress Press 2025 Year-end & Q4 Financial Results and Update Date published: March 10, 2026 1:57 pm PDT Share Related Documents: News Release Conference Call Conference Call Presentation
SKYE Neutral Sentiment
2025 Year-end & Q4 Financial Results and Update
Key Takeaway: The article discusses the financial results for the year-end and Q4 of 2025 for SKYE. It mentions the publication date of March 10, 2026, and includes references to related documents such as a news release and a conference call presentation. However, specific financial details or insights are not provided in the text.
Price reaction · baseline $0.7194 (2026-03-10T13:56:00.000Z) · hit during market hours · clean, no other SKYE news in the window
day 0 close · peak
+11%
day 1
+0.3%
day 3
-8.2%
Market Sentiment Analysis
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+84%
120-day peak, hindsight
Typical move
24.3%
average across 4 past catalysts
Cash runway
~4 mo
High dilution risk
Lead asset
Nimacimab
Phase 2 · Obesity